C. diff. Foundation Waives Registration Fees Again for 2018 International Conference & Expo

Banner promotion for 6th C. diff. Foundation 2018 International Conference & Health ExpoThe C. diff. Foundation has once more extended a special offer to faculty, fellow and resident trainees, and students at the UA Department of Medicine for free registration at the Sixth Annual C. diff. International Conference & Health Expo on Nov. 8-9 in Philadelphia.

Join 200 health-care professionals to share the latest data on the prevention, treatments, environmental safety focused on Clostridium difficile infection (CDI), a healthcare-associated infection, irritable bowel syndrome and disease (IBS/IBD), as well as fecal transplant procedures and more.

Thursday, Nov. 8 – 8 a.m.-4 p.m.
Friday, Nov. 9 – 8 a.m.-3 p.m.
Embassy Suites by Hilton – Philadelphia Airport
9000 Bartram Avenue
Philadelphia, PA 19153

Those interested in taking advantage of the waived registration should email Nancy Caralla, foundation executive director, at ncaralla@cdifffoundation.org — they should receive an email confirmation from the C. diff. Foundation shortly afterward.

Rooms at the host hotel, Embassy Suites, are discounted to $159, with less expensive accommodations nearby.

Guest Speakers

Among speakers invited to address conference participants are:

Mark Wilcox, MD, FRCPath — Conference co-chair, he serves as a consultant microbiologist, head and professor of medicine and academic lead of pathology/clinical director of pathology at the Leeds Teaching Hospitals (LTHT). Dr. Wilcox is a professor of medical microbiology at the University of Leeds at the Institute of Biomedical and Clinical Sciences and is the lead on Clostridium difficile for Public Health England in the UK. He serves as the principal/UK investigator for several clinical trials of new anti-infective drugs and has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents. He serves as assistant editor of the Journal of Antimicrobial Chemotherapy and is a member of the Council of the British Society of Antimicrobial Chemotherapy. In addition, he serves as a member of the Department of Health’s Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Committee and an advisor to the UK Healthcare Commission, the Medicines and Healthcare products Regulatory Agency, the EPIC project on infection control issues, the Health Technology Assessment (HTA) programme on Healthcare Associated Infection and the European Centre for Disease Control. Dr. Wilcox also serves as a member of UK, European and U.S. working groups on Clostridium difficile infection.

Dale Gerding, MD, FACP, FIDSA — Conference co-chair, Dr. Gerding is a professor of medicine at Loyola University Chicago’s Stritch School of Medicine in Maywood, Ill., and a research physician at the Edward Hines Jr. VA Hospital. He was previously chief of medicine at VA Chicago, Lakeside Division, and professor of medicine at Northwestern University’s Feinberg School of Medicine. He is an infectious diseases specialist and hospital epidemiologist, past president of the Society for Healthcare Epidemiology of America (SHEA) and past chair of the antibiotic resistance committee of SHEA. He is a fellow of the Infectious Diseases Society of America (IDSA) and past chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA.

Paul Feuerstadt, MD, FACG — A native of Long Island, N.Y., Dr. Feuerstadt attended the University of Pennsylvania where he earned his bachelor’s degree in biology, with distinction in research and graduated Summa Cum Laude. Afterward, he attended the Weill Medical College at Cornell University in Manhattan, where he earned his medical degree and stayed on at Weill Cornell/New York Presbyterian Hospital for his internship and residency in internal medicine. He completed his clinical fellowship training at Montefiore Medical Center in the Bronx. His areas of interest include ischemic diseases of the gut and chronic diarrheal syndromes with a specific focus on C. diff. infections. Dr.Feuerstadt is affiliated with St. Raphael campus of Yale-New Haven Hospital, Yale-New Haven Hospital and Milford Hospital seeing outpatients in his offices in Hamden and Milford, Conn.

Others include:

  • Edmond A. Hooker, MD, DrPH — Department of Health Services Administration at Xavier University
  • Stuart B. Johnson, MD, FIDSA, DTM&H — professor, Department of Medicine, Stritch School of Medicine, Loyola University, Chicago
  • Sahil Khanna, MD — Assistant Professor of Medicine in the Division of Gastroenterolgy and Hepatology at Mayo Clinic, Rochester, Minn.
  • Nicola Petrosillo, MD, FESCMID — professor, Infectious Diseases, Medical School of Specialization in Hygiene, Tor Vergata University, Rome, and director, Clinical and Research Department, Lazzaro Spallanzani National Institute for Infectious Diseases
  • Norman B. Javitt, MD, PhD — research doctor in New York City
  • Nick Van Hise, PharmD, BCPS — Metro Infectious Disease Consultants, C diff. Foundation

For more details on the speakers, their topics and the conference, click here: https://cdifffoundation.org/2018cdiffconference/

“Attend C. diff. Awareness Conference Free of Charge, Nov. 9-10, Las Vegas” | Posted Sept. 20, 2017
“DOM Blog – Quality & Safety: Had a patient with C. diff. lately?” | Posted April 21, 2016

Release Date: 
06/12/2018 - 8:00pm